Global /India /Healthcare /Drug Manufacturers - General /INFINIUM
chevron_leftBack
Infinium Pharmachem Ltd. logo

Infinium Pharmachem Ltd.

INFINIUM
NSE: INFINIUM Delayed
216.25INR 2%
2.27 USD
As of 13 July 2026, Infinium Pharmachem Ltd. has a market cap of $34.65M USD, ranking #33206 globally and #2219 in India. It ranks #2993 in the Healthcare sector, and #1027 in the Drug Manufacturers - General industry.
Global Rank
33206
1d: 0
1w: +4
1m: -
Country Rank
2219
1d: 0
1w: +2
1m: -
Sector Rank
2993
1d: 0
1w: +2
1m: -
Industry Rank
1027
1d: 0
1w: +2
1m: -
Key Stats
Market Cap
$34.65MUSD
3.3B INR
Enterprise Value
$36.81MUSD
3.51B INR
Revenue (TTM)
$16.45MUSD
1.57B INR
EBITDA (TTM)
$1.94MUSD
185.37M INR
Net Income (TTM)
$979.76KUSD
93.4M INR
EBITDA Margin
12%
Profit Margin
6%
PE Ratio
34.9
PS Ratio
2.1
PB Ratio
2.5
EV/EBITDA
18.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Sanjaykumar Patel open_in_new
Employees
144
Founded
2003
Website
infiniumpharmachem.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2% -0.7% 6.3% -3.5% -15% -30%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
INFINIUM
Infinium Pharmachem Ltd Ordinary Shares
ISIN: INE0MRE01011
Shares Out.:
15.583M1 Shares Float: 6.549M2
TV:
SA:
YF:
GF:
BA:
MS:
216.25 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Infinium Pharmachem Ltd.

Infinium Pharmachem Limited engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally. The company provides iodine based molecules/APIs/iodination reaction based bulk drugs. It also offers potassium iodide and iodate, sodium iodide, iodine, povidone iodine, pralidoxime iodide, thymol iodide, and iodoform products. In addition, the company provides contract research and manufacturing services to pharmaceutical and biotech companies for iodine based APIs and intermediates. It serves pharmaceutical and biotech, specialty and performance chemicals, dairy, food and nutraceutical, animal care, agrochemical, paints, coatings, dyes and textile, ink, paper and printing, rubber and nylon tyre, oil and gas, gold imitation and jewelry, medical, radiography, nuclear science, gemological, renewable energy, electrical, electronics, mechanical, aquarium, photography, tobacco, and fireworks, as well as cosmetics, sanitation, personal care, and industrial care industries. The company was incorporated in 2003 and is based in Anand, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$44.77B
4.27T INR
129K%
39.1
DIVISLAB
$18.2B
1.73T INR
52K%
70.0
$15.02B
1.43T INR
43K%
63.0
$11.62B
1.11T INR
33K%
19.6
MANKIND
$9.77B
931.67B INR
28K%
52.2
ZYDUSLIFE
$9.61B
916.53B INR
28K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
2M%
38.1
JNJ
$547.28B
2M%
26.4
ABBV
$360.63B
1M%
97.4
$316.87B
256.25B CHF
914K%
19.9
AZN
$289.23B
215.59B GBP
835K%
27.6
MRK
$274.03B
791K%
15.1
chevron_leftBack